Flavonoid dimers from the total phenolic extract of Chinese dragon's blood, the red resin of Dracaena cochinchinensis
- 1 December 2016
- journal article
- Published by Elsevier in Fitoterapia
- Vol. 115, 135-141
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81573572)
- Program for New Century Excellent Talents in University (NCET-13-0693)
- Beijing University of Chinese Medicine (2016-JYB-XS085)
This publication has 17 references indexed in Scilit:
- Isolation and chatacterization of homoisoflavonoids from Dracaena cochinchinensis and their osteogenic activities in mouse mesenchymal stem cellsJournal of Pharmaceutical and Biomedical Analysis, 2016
- Chalcane–stilbene conjugates and oligomeric flavonoids from Chinese Dragon’s Blood produced from Dracaena cochinchinensisPhytochemistry, 2015
- Anti-neuroinflammatory sesquiterpenes from Chinese eaglewoodFitoterapia, 2015
- Anti-inflammatory Labdane Diterpenoids from Leonurus macranthusJournal of Natural Products, 2015
- Dihydrochalcones and homoisoflavanes from the red resin of Dracaena cochinchinensis (Chinese dragon's blood)Fitoterapia, 2014
- A Systematic Review of the Botanical, Phytochemical and Pharmacological Profile of Dracaena cochinchinensis, a Plant Source of the Ethnomedicine “Dragon’s Blood”Molecules, 2014
- Anti-inflammatory Labdane Diterpenoids from Lagopsis supinaJournal of Natural Products, 2014
- Natural potential therapeutic agents of neurodegenerative diseases from the traditional herbal medicine Chinese Dragon׳s BloodJournal of Ethnopharmacology, 2014
- Anti-neuroinflammatory constituents from Polygala tricornis GagnepFitoterapia, 2012
- Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysisPathophysiology, 2010